Patent echoes for Viralytics
30 March, 2009 by Kate McDonaldViralytics granted patent in US for oncolytic echoviruses
TGR’s Crouch wins BioBusiness award
30 March, 2009 by Kate McDonaldTGR BioSciences CSO Michael Crouch wins Advancing BioBusiness Award
Biota partner to market
30 March, 2009 by Kate McDonaldBiota’s partner Daiichi Sankyo applies for marketing licence, finishes Phase III enrolment
Australian biotech market today 26.03.09
26 March, 2009 by Staff WritersCochlear, CSL, Progen, Genera Biosystems, Peplin
Better red than dead
20 March, 2009 by Kate McDonaldFemale finches bias the gender of offspring depending on head colour
Australian biotech market today 19.03.09
19 March, 2009 by Staff WritersCSL, Cochlear, Resmed, Genera, Starpharma, Novogen
Alchemia collaborates on SK1
19 March, 2009 by Kate McDonaldAlchemia in deal with private firm SDP for sphingosine kinase 1 target
Ventracor’s heart gives out
19 March, 2009 by Kate McDonaldVentracor in voluntary administration after failing to secure funds
Rabies infection from dog meat
19 March, 2009 by Kate McDonaldTwo cases of rabies infection from eating dog and cat meat reported
Australian biotech market today 18.03.09
18 March, 2009 by Kate McDonaldAlchemia, Avexa, Cytopia, Genera Biosystems, Universal Biosensors
Australian biotech market today 17.03.09
17 March, 2009 by Kate McDonaldAvexa, Cochlear, Acrux, Peplin, Clinuvel, pSivida
Positive results for Avexa
16 March, 2009 by Staff WritersAvexa reports impressive results for apricitabine in HIV+ patients
Australian biotech market today 16.03.09
16 March, 2009 by Kate McDonaldCochlear, CSL, Resmed, Sonic Healthcare, Avexa, Novogen, Alchemia, Biotron
Generic opportunity for Alchemia
13 March, 2009 by Kate McDonaldAlchemia’s partner files generic application for fondaparinux
pSivida eyes Iluvian
13 March, 2009 by Kate McDonaldGood early results for pSivida’s intra-vitreal insert
